-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $70 at Leerink Partners
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
-
-
-
-
-
-
-
Mereo BioPharma (MREO) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
JPMorgan Starts Mereo BipPharma Group (MREO) at Overweight
-
-
-
-
-
-
-
Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS
-
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

